Interestingly, we found that the expression of AR and FGF19 genes was higher in the subclass of tumours with strong cell proliferation and anti-apoptosis gene expression signatures, corresponding to patients with poorer prognosis (reduced survival) [41] (Figure 9 C). This evidence concerns the gene FGF19 and neoplasm.